Global Chikungunya Fever Market - Overview
Chikungunya fever is a disease caused by mosquito bites. It is an RNA virus that belongs to the alphavirus genus of the family Togaviridae. The disease is transmitted via human to human by the bites of female mosquitoes that are infected. The most commonly involved mosquitoes are Aedesalbopictus and Aedesaegypti. Symptoms includes nausea, headache, rashes,fatigue and muscle pain. There are no drug available for the treatment of Chikungunya fever. The global Chikungunya Fever Market is expected to grow at a CAGR of 5.8% during the forecast period. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/4694 Moreover, treatment are available for relieving the symptoms of this disease. In allopathy, the use of optimal analgesics andanti-pyretics are preferred treatment option. While, for homeopathy and ayurvedaspecific treatment procedures are employed. As per the World Health Organization (WHO), the disease mostly occurs in Asian countries such as the Indian subcontinent and other African regions. Nevertheless, there was major outbreak of this disease in 2015 that affected several countries in the Americasregion. Incidents such as this is projected to boost the market growth across the globe during the forecasted period. Globally, more than 60 countrieshad reported Chikungunya fevercases for all regions including Africa continents, Americas, Europe,and Asia Oceanic.According to the World Health Organizationin 2016, there were 349 936 suspected with more than 146 914 laboratory confirmed cases of chikungunya reported to the (Pan American Health Organization)PAHO regional office. Countries such as Brazil reported the most severe cases with 265 000 suspected cases followed by Bolivia and Colombia at 19 000 suspected cases. Competitive Landscape: Bio-Rad Laboratories, Inc. (U.S.A), Alere. (U.S.A), Genome Diagnostics Pvt. Ltd. (India), Quest Diagnostics Incorporated. (U.S.A), Taj Pharmaceuticals Limited. (India), altona Diagnostics (Europe), Etubics Corporation (U.S.A), Sanat Products Ltd. (India) Global ChikungunyaFever Market - Regional Analysis The global Chikungunya Fever Drugs Market Size is divided into four regions namely Americas, Europe, Asia Pacific and the Middle East and Africa. The Americas dominate the global chikungunya fever market owing to a strong government support for research & development, high healthcare spending,and large patient population. Besides, the regions facilitates the presence of the global market leaders which contribute the major growth of the global chikungunya fever during the forecasted period.North America is further segmented into the US and Canada. A well-developed healthcare sector, high healthcare spendingand huge geriatric & patient population will boost the market in North America. However, South America shows the fastest growth for the market due to the presence of huge opportunities for the development of the market. Browse More Report Details @ https://www.marketresearchfuture.com/reports/chikungunya-fever-market-4694 The Europe has the second leading market in global chikungunya fever market which is followed by Asia Pacific. Asia Pacific is the fastest growing market for chikungunya fever. According to the European Centre for Disease Prevention and Control there were about 102 autochthonous chikungunya cases in 2017in Italy. Furthermore, similar cases were reported in France. Factorssuch as the high per capita healthcare expenditures along with presence of the well-developed healthcare infrastructure made the Europe to generate huge revenues for the global chikungunya fever market. Indian and China were the prominent market that majorly drives the Asia Pacific chikungunya fever market owing to a continuously developing healthcare sector and huge patient pool.According to the World Health Organization, the major outbreaks of chikungunya fever are seen in Asia and the Indian subcontinent. Rendering to the Indian Brand Equity Foundation, per capita healthcare expenditure was estimated to grow at a CAGR of 5 % during 2015 and will reach USD 68.6 by 2015. The Middle East and Africa contribute the least in the growth of the global chikungunya fever market. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East market. The Middle East dominates the market for The Middle East and Africa. Africa holds the least share of the global chikungunya fever market due to limited availability of medical facilities and poor economic condition. However the growth of the Africa market is high due to the presence of opportunities for the development of the market. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
0 Comments
Market Overview: Considering the kind of the growth, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global Dental Amalgam Market will reach up to USD 500 MN by 2023 with approx. 5% CAGR during the review period (2017 – 2023). Dental Amalgam has long been the popular cavity filling choice for dentists because of its strength and durability. A cavity is a common dental problem caused by a build-up of plaque, a sticky substance made up of bacteria. Due to the widespread cavity concerns, dental amalgam witnesses a huge demand all over the world. Resultantly, the dental amalgam market is growing pervasively on the global platform. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/3789 Silver amalgam fillings that have been a staple of dentistry since decades consist of approximately 50 percent mercury, a known toxin that can cause harmful effects in humans. Despite the presence of mercury, the U.S. FDA considers amalgam fillings safe for adults and children over six years old. However, traditional amalgam materials present some challenges, such as the unsightly contrast to the teeth color, expansion and contraction of materials due to hot or cold liquids that could lead to a higher rate of fractures in the surrounding tooth and increased sensitivity. To tackle these issues, composite cavity filling has been created to protect the teeth from unseen decay. Composite amalgam offers a reliable, durable, and aesthetics alternative for small- to medium-sized cavities, creating a better seal. Performance characteristics of composite amalgam have improved over the years to now rank as the most popular option. The ability to closely match the color to natural teeth makes composites a viable option for both front and back teeth. Besides, composites offer superior bonding capabilities to the tooth structure. The emergence of composite fillings has given rise to the market, increasingly encouraging people to opt for the Amalgam, which in turn, augments the market demand for dental amalgam. The cosmetic dentistry treatment market also supports the dental amalgam market. Furthermore, growing oral healthcare concerns worldwide, fuel the market growth predominantly. Increasing awareness among people about oral health plays a major role in fostering the Dental Amalgam Market Size . Global Dental Amalgam Market – Competitive Landscape The fiercely competitive market of dental amalgam appears to be fragmented with the presence of many well-established players having the global presence. Brand reinforcement, mergers & acquisitions, and innovation remain the popular trends for the key players in the market. Key Players: Patterson Dental, DMP Dental, APL Materials, Nanjing FoiNoe Co., Ltd., DMP, AT&M Biomaterials Co., Ltd., Kerr Corporation, BOME, Benco Dental Supply Company, and Henry Schein Global Dental Amalgam Market – Segmentations MRFR has segmented its analysis into five key dynamics for an easy grasp; By Particle Shapes : Lath Cut Particles, Spherical Particles, and Admixed Particles among others. By Particle Sizes : Micro Cut, Fine Cut, and Coarse Cut among others. By Metals : Noble Metals (gold, silver, other), and Non-noble Metals (copper, gallium, others) among others. By Number of Alloy Metals : Binary Alloy, Ternary Alloy, and Quaternary Alloy among others. By Regions : North America, Europe, APAC and Rest-of-the-World. Global Dental Amalgam Market – Geographical Analysis Geographically, the North American region accounts for the leading market for dental amalgam, capturing the largest market share followed by the European & Asia Pacific region, respectively. High expenditure on health care is the main driving force for the market growth in North America. Moreover, burgeoning market in the US backed by the substantial investments significantly contributes to the market growth in the region. Additionally, increasing demand for dental amalgam due to the prevailing dental problems such as tooth decay provides impetus to the market growth. Continuing with the same trends, the North America dental amalgam market is expected to create a larger revenue pocket in the global market by 2023. The European region is the world’s second-largest market for dental amalgam. The market is driven by the high per capita health care expenditures and well-established healthcare sector in the region. Countries such as the UK, Germany, and France backed by the huge investments drive the regional market growth at a large scale. With the increasing investment in health care and the rising number of patients with dental diseases, the dental amalgam market in Europe is projected to register a phenomenal CAGR during the assessment period. Access Full Report Details @ https://www.marketresearchfuture.com/reports/dental-amalgam-market-3789 The Asia Pacific dental amalgam market is expected to perceive an exponential growth, emerging as a promising market for the product. Growing markets of India & China backed by the vast population and the burgeoning medical treatment foster the market growth in the region. Furthermore, Vietnam, Thailand, and Malaysia among the other South East Asian countries are projected to contribute significantly to the regional market growth
Market Synopsis of Global Anti-ageing drugs Market: “Botox has helped her get ready faster!” said Kelly Ripa on the show “Watch What Happens Live with Andy Cohen”. Gone is the time when one would find anti-ageing products only in the cabin baggage of international flights and the makeup rooms of top notch artists! Anti-aging drugs are used to slow down or reverse the process of aging in order to extend the lifespan. Anti-ageing drugs are no longer taboo even in dusky small towns. Today’s women even from developing countries are as modern and demanding as their western counterparts. Thus we expect the differential between west and east regarding anti-ageing drugs to fall from its colossal heights of the 80’s! The global Anti-Ageing Drugs Market is expected to reach USD 124,896.6 million by 2023, and the market is projected to grow at a CAGR of ~ 13.3 % during the forecast period 2017-2023. Key Players in the Global Anti-Ageing Drugs Market: Nu Skin, BIOTIME, INC., Elysium Health Inc., La Roche-Posay, DermaFix, L'ORÉAL Market dynamics of Global Anti-ageing drugs Market: The global anti-ageing drugs market is driven by factors such as the rising number of ageing population, growing demand for anti-aging drugs, influence of media and fashion industry, and primal demand to be young. The social and attitudinal aspects of a region or nation also have a large impact on the market and so is the influence of the media. Anti-aging drugs market is currently in its infant stage and there is a lot of scepticism about its future. According to the World Health Organization (WHO), the proportion of the world's population over 60 years between 2015 and 2050 will nearly double from 12% to 22%. Further, as per WHO estimates, by 2020, the number of people aged 60 years and older will outnumber children younger than 5 years and by 2050, 80% of older people will be living in low- and middle-income countries. Critical market constraints are scepticism, concerns of safety, stringent regulations and definition ambiguity etc. Many spurious products with dubious claims are easily available on the web that has spurred a flood of self-proclaimed experts proposing growth hormones, skin-care products, beta glucan, and a variety of dietary and nutritional supplements with claims that are difficult to validate. The definition issues are also huge as the Food and Drug Administration has repeatedly warned many producers of anti-ageing medicines of such claims. The definition of cosmeceuticals is not agreed by many administrative bodies. There are issues of counterfeit products and misbranding, which reduces the market for quality products from reputed manufacturers. Lack of experimental studies to validate the claims made by manufacturers has complicated the situation. Segments of Global Anti-ageing drugs Market The global anti-ageing drugs market has been segmented on the basis of drug class and applications. On the basis of drug class, the market is segmented into serums and supplements, antioxidants and enzymes, stem cells and drugs. On the basis of application, the market is segmented into skin and hair, skeletal and muscles, age related disorders and others. Serums and supplements segment commanded the largest market share in 2016 and is expected to reach USD 51,590.5 million by the end of 2023. Furthermore, stem cells segment is expected to be the fastest growing market which is expected to grow at a CAGR of 16.6 % during the forecast period 2017-2023. Skin and hair segment commanded the largest market share in 2016. This market is expected to reach USD 72,222.3 million by 2023, at a CAGR of 15.9 % during the forecast period 2017-2023 Regional Analysis of Global Anti-ageing drugs Market The Americas holds a significant market share followed by Europe. The high per capita income of the US, the presence of large innovative players in healthcare of the U.S. regions drive the anti-ageing drugs market. The ageing population of baby boomers is expected to propel the market in the US. North America held the largest market share in 2016. This market is expected to reach USD 42,470.5 million by 2023, at a CAGR of 13.4 % during the forecast period of 2017-2023 Europe is the second largest market in the globe due to a high healthcare expenditure and influence of media industry.Asia Pacific region is expected to grow rapidly; Japan, China and India are likely to lead the market due to unmet needs during the forecasted period. APAC is expected to grow at a higher CAGR of 15.3 % than the other regions because of increasing ageing population in this region. Market Overview:
Dental Amalgam has long been the popular cavity filling choice for dentists because of its strength and durability. A cavity is a common dental problem caused by a build-up of plaque, a sticky substance made up of bacteria. Due to the widespread cavity concerns, dental amalgam witnesses a huge demand all over the world. Resultantly, the dental amalgam market is growing pervasively on the global platform. Considering the kind of the growth, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global Dental Amalgam Market will reach up to USD 500 MN by 2023 with approx. 5% CAGR during the review period (2017 – 2023). Silver amalgam fillings that have been a staple of dentistry since decades consist of approximately 50 percent mercury, a known toxin that can cause harmful effects in humans. Despite the presence of mercury, the U.S. FDA considers amalgam fillings safe for adults and children over six years old. However, traditional amalgam materials present some challenges, such as the unsightly contrast to the teeth color, expansion and contraction of materials due to hot or cold liquids that could lead to a higher rate of fractures in the surrounding tooth and increased sensitivity. To tackle these issues, composite cavity filling has been created to protect the teeth from unseen decay. Composite amalgam offers a reliable, durable, and aesthetics alternative for small- to medium-sized cavities, creating a better seal. Performance characteristics of composite amalgam have improved over the years to now rank as the most popular option. The ability to closely match the color to natural teeth makes composites a viable option for both front and back teeth. Besides, composites offer superior bonding capabilities to the tooth structure. The emergence of composite fillings has given rise to the market, increasingly encouraging people to opt for the Amalgam, which in turn, augments the market demand for dental amalgam. The cosmetic dentistry treatment market also supports the dental amalgam market. Furthermore, growing oral healthcare concerns worldwide, fuel the market growth predominantly. Increasing awareness among people about oral health plays a major role in fostering the market growth. Global Dental Amalgam Market – Competitive Landscape The fiercely competitive market of dental amalgam appears to be fragmented with the presence of many well-established players having the global presence. Brand reinforcement, mergers & acquisitions, and innovation remain the popular trends for the key players in the market. Key Players: Patterson Dental, DMP Dental, APL Materials, Nanjing FoiNoe Co., Ltd., DMP, AT&M Biomaterials Co., Ltd., Kerr Corporation, BOME, Benco Dental Supply Company, and Henry Schein Global Dental Amalgam Market – Segmentations MRFR has segmented its analysis into five key dynamics for an easy grasp; By Particle Shapes : Lath Cut Particles, Spherical Particles, and Admixed Particles among others. By Particle Sizes : Micro Cut, Fine Cut, and Coarse Cut among others. By Metals : Noble Metals (gold, silver, other), and Non-noble Metals (copper, gallium, others) among others. By Number of Alloy Metals : Binary Alloy, Ternary Alloy, and Quaternary Alloy among others. By Regions : North America, Europe, APAC and Rest-of-the-World. Global Dental Amalgam Market – Geographical Analysis Geographically, the North American region accounts for the leading market for dental amalgam, capturing the largest market share followed by the European & Asia Pacific region, respectively. High expenditure on health care is the main driving force for the market growth in North America. Moreover, burgeoning market in the US backed by the substantial investments significantly contributes to the market growth in the region. Additionally, increasing demand for dental amalgam due to the prevailing dental problems such as tooth decay provides impetus to the market growth. Continuing with the same trends, the North America dental amalgam market is expected to create a larger revenue pocket in the global market by 2023. The European region is the world’s second-largest market for dental amalgam. The market is driven by the high per capita health care expenditures and well-established healthcare sector in the region. Countries such as the UK, Germany, and France backed by the huge investments drive the regional market growth at a large scale. With the increasing investment in health care and the rising number of patients with dental diseases, the dental amalgam market in Europe is projected to register a phenomenal CAGR during the assessment period. The Asia Pacific dental amalgam market is expected to perceive an exponential growth, emerging as a promising market for the product. Growing markets of India & China backed by the vast population and the burgeoning medical treatment foster the market growth in the region. Furthermore, Vietnam, Thailand, and Malaysia among the other South East Asian countries are projected to contribute significantly to the regional market growth Market Analysis
There are many factors that is driving the growth of the veterinary surgical instruments market.Some of these factors as per the Market Research Future (MRFR) report include rising need for veterinary surgical instruments, rising need for pet insurance, increasing awareness for animal health, rising animal healthcare expenditure, increase in veterinary practitioners, increase in trauma and soft tissue surgeries in animals, growing pet acceptance, product innovation, technological advancements, increased expenditure on research and development and increasing number of animal welfare laws and regulations and veterinary hospitals. On the other hand, factors such as dearth of veterinarians especially in emerging countries, lack of awareness regarding animal health and strict regulatory guidelines related to accuracy, efficacy and safety of veterinary surgical instruments are likely to hamper the growth of the veterinary surgical instruments market. The global Veterinary Surgical Instruments Market is anticipated to grow at a splendid 6.3% CAGR over the forecast period (2017-2023). The veterinary surgical instruments have been specially designed for performing surgical procedures on different animals. These instruments are selected resting on its function which includes to hold, pull, clamp, cut, crush and close a wound. The surgical instruments are categorized into various types based on function and design. It is made of martensitic or austenitic stainless steel. Various forms of surgery need various forms of surgical instruments. Some of the common surgery types include orthopedic surgery, ophthalmic surgery, surgical oncology, dental surgery, and sterilization surgery. The other procedures include foreign body removal, wound repair, cystotomy, bloat surgery, caesarean section and others. Key Players: Medtronics, B.Braun, Whittemore Enterprises, Inc.,Sklar Instruments,Surgical Holdings, Jørgen KRUUSE A/S, Eickemeyer Veterinary Equipment Inc Market Segmentation Market Research Future report offers an all-inclusive segmental analysis of the veterinary surgical instruments market on the basis of type, application and animals. Based on type, it is segmented into retractors, needle holders, scissors, dressing, forceps and scalpel handles. Based on applications, the veterinary surgical instruments market is segmented into dental, ophthalmic, sterilization and orthopedic. Based on animals, it is segmented into large animals, felines and canines. Of these, large animals will lead the veterinary surgical instruments market due to rising occurrence of chronic diseases of equine animals, rising animal healthcare spending in the developing countries and increasing awareness in government animal healthcare organizations. Regional Analysis Based on region, the veterinary surgical instruments marketcovers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, the US will grab the maximum share in the market owing to the presence of organized and large dairy and meat industry and the favorable reimbursement scenario here. Europe has the second largest share owing to increasing awareness regarding animal health, changing disease pattern and the government and many NGO’s working to augment animal healthcare. The veterinary surgical instruments market in the APAC region is anticipated to expand at the fastest pace owing to rising awareness and demand and the presence of a good number of veterinarians in this region. The veterinary surgical instruments market in this region is led by India and China. On the other hand, the veterinary surgical instruments market in Middle East and Africa will have a limited growth due to lack of knowledge concerning diseases, dearth in the availability of expert veterinary professionals and lack of access for veterinary healthcare. Competitive Analysis The veterinary surgical instruments market is highly competitive and is characterized by the existence of numerous key players. The major players amidst intense competition in the market are constantly laying emphasis on attaining higher share through agreements, collaborations and new product launches. The market by nature is fragmented with many companies constantly giving their efforts in marking their presence. Overview:
Diabetes is a problem that gets triggered by irregularities in the lifestyle. Often the food intake pattern affects various physical aspects. In addition, the sedentary lifestyle is impacting the fitness, which leads to diabetes. It has a direct connection with obesity, which is one of the major reasons behind fatal incidents worldwide. Diabetes can be hereditary as well. People in India are fast becoming aware of the impacts of this disease and are opting for early diagnosis to maintain better health standard. The problem is becoming a concern mostly in the urban areas. The India Diabetes Market report, as revealed by Market Research Future (MRFR), has a chance to grow with a 6.5% CAGR during the forecast period of 2016 to 2023. By 2023, the valuation of the India diabetes market would reach USD 7441.6 million. In the report, MRFR discussed the possibilities of achieving growth by benefiting from the opportunities provided by various states to pharmaceuticals. This would be to meet the growing need of diabetes patients. Better exposure to such diseases is helping people understand the consequences of it and influencing them to get timely treatments. Along with this, a hike in disposable income is helping people in focusing on such needs. Segmentation: The India diabetes market has been studied on the basis of a segmentation that includes type, test, devices, and treatment. These segments would help the market in gaining a better understanding of how to plan strategies by optimally using resources. By type, the India diabetes market report includes gestational diabetes, type 1, and type 2. By test, the report on the India diabetes market includes random blood sugar test, fasting blood sugar test, initial glucose challenge test, oral glucose tolerance test, and others. By devices, the report on the India diabetes market can be segmented into Diabetes management devices, Blood glucose monitoring devices, and others. By treatment, the report on the India diabetes market can be segmented into Bariatric Surgery, Insulin therapy, Transplantation, Medications, and others. Regional Analysis: The regional market of India diabetes has been studied to get a thorough understanding of how the market can work in the coming days. This includes demographic challenges in various states and other factors that can ensure growth. The India diabetes market has been segmented into five definite regions like North, West, East, South, and Central. The western region has the opportunity of achieving better growth with states like Gujarat and Maharashtra showing a decent scope for growth. This is primarily because the zonal awareness regarding the disease is quite high and various market players are getting ample scope to operate. Business is getting favorable winds. The Northern and Eastern markets are also showing ample growth opportunities. However, the North-East segment may find the growth to be slackening as the region has very poor economic growth and accessibility. In the South, the development of some major urban cities would help the India diabetes market in its growth. Regional awareness, the presence of several pharmaceutical companies, and others would ensure that the market gets easy growth opportunities. Competitive Landscape: The India diabetes market is growing rapidly due to the continuous efforts from companies like USV Private Limited (India), Novo Nordisk A/S (Denmark), Novartis AG (Switzerland), Sanofi-aventis U.S. LLC (US), Becton Dickinson and Company (US), Merck & Co., Inc. (US),Bayer AG (Germany), Johnson & Johnson Services, Inc.(us), Roche Diabetes Care, Inc.(US),Ypsomed (Switzerland), and others. These companies are investing much in their strategic development to gain leverage from the huge patient pool. Their strategies often include moves like mergers, acquisitions, collaborations, hike in investment for research & development, and various other methods. Industry News: In February 2020, the pharmaceuticals giant AstraZeneca announced that they are launching Qtern tablets that are needed for the type 2 diabetes. This would help the company to make an impact on the market by exploring its possibilities in the region. In February 2020, researchers from IISc revealed that the malnutrition level in the fetus is growing owing to which Indians are becoming vulnerable to diseases like diabetes. |